Original Article

Outcomes and Adverse Events Linked to Off-Label Treatment of Solid Tumors with PARP Inhibitors

Bestis Wasef, PharmD, BCOP; Kelly Fritz, PharmD, BCOP; Courtney C. Cavalieri, PharmD, BCOP

Impact of Pharmacist Telephone Follow-Up on Chemotherapy-Induced Nausea and Vomiting

Jenny McCabe, PharmD; Amanda Al-Bahou, PharmD, BCOP; Leann Koontz, PharmD, BCPS, BCOP; Linda Linderbeck, PharmD, BCOP; Michael Verbosky, PharmD, BCPS; Michelle Prieto, PharmD

Evaluating Institutional Safety Standards Related to Continuing Oral Antineoplastic Medication Use During Hospitalization

Belinda Li, PharmD, BCOP; Laura Beth Parsons, PharmD, BCOP; Darby Siler, PharmD, BCOP; Rachel Matthews, PharmD, BCOP

Time to First Palbociclib Prescription Dispense at Mayo Clinic: Comparing a Health-System Specialty Pharmacy with External Specialty Pharmacies

Allison P. Golbach, PharmD; Jodi L. Taraba, PharmD; Matthew D. Smith, PharmD; Kristin C. Mara, MS; Karthik V. Giridhar, MD

Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Newman, PharmD; Sara E. Gordon, PharmD, BCOP; Charles J. Nock, MD; Christopher J. Burant, PhD; Candice M. Wenzell, PharmD, BCOP

The Link Between Hypoalbuminemia and Oral Tyrosine Kinase Inhibitor Adverse Events in Adults with Malignant Solid Tumors

Jessica Marini, PharmD, BCOP; Bailey Bass Hammond, PharmD; Jacob Rennebaum, PharmD; Erin Weeda, PharmD, BCPS; Jagoda Misniakiewicz, PharmD; Amy Sion, PharmD, BCOP

Safety and Efficacy of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients with Cancer and Baseline Renal Dysfunction

Emily H. Hsu, PharmD, and Ryan Beechinor, PharmD, BCPS, BCOP

Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma

Tia M. Stitt, PharmD; Katherine M. Saunders, PharmD, BCOP; Brooke C. Rowling, PharmD Candidate; Jennifer L. Waller, PhD; Amber B. Clemmons, PharmD, BCOP, FHOPA

Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials

Jacqueline Saunders, PharmD, BCPS; Sumati Murli, PhD; Michelle A. Rudek, PharmD, PhD; Anand Khandoobhai, PharmD, MS; Anne DeLisa, PharmD, CCRP; Amy Goodrich, RN, MSN, CRNP-AC; Janet Mighty, BS Pharm, MBA

Comparing Single-Center Outcomes Between Reference and Biosimilar Granulocyte Colony-Stimulating Factor Drugs Used for Autologous Stem-Cell Mobilization

Trace Bartels, PharmD; Molly Klanderman, PhD, MS; Jaime Rogers, MSN, RN; Kristin Gray, MSN, RN; Heidi Kosiorek, MS; Chris Coughlin, PharmD, BCOP

Page 2 of 12
Results 11 - 20 of 115

Subscribe Today!

I'd like to receive:

Original Article